The Global Recombinant Plasma Protein Therapeutics Market was valued at US$ 8.2 Bn in 2020. It is anticipated expand at a CAGR of 8% from 2022 to 2028. Recombinant proteins are produced by combining DNA fragments from different organisms. Recombinant proteins often come from mice, bacteria or yeast and can be used to treat human diseases. They […]
